These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 19527764
41. Characteristics of bipolar disorder in an Australian specialist outpatient clinic: comparison across large datasets. Mitchell PB, Johnston AK, Corry J, Ball JR, Malhi GS. Aust N Z J Psychiatry; 2009 Feb; 43(2):109-17. PubMed ID: 19153918 [Abstract] [Full Text] [Related]
42. The association of oxidative stress and disease activity in seborrheic dermatitis. Emre S, Metin A, Demirseren DD, Akoglu G, Oztekin A, Neselioglu S, Erel O. Arch Dermatol Res; 2012 Nov; 304(9):683-7. PubMed ID: 22699428 [Abstract] [Full Text] [Related]
43. Increased oxidative stress in patients with pseudoexfoliation syndrome. Cumurcu T, Gunduz A, Ozyurt H, Nurcin H, Atis O, Egri M. Ophthalmic Res; 2010 Nov; 43(4):169-72. PubMed ID: 20068368 [Abstract] [Full Text] [Related]
44. Role of free radicals and antioxidants in nasal polyps. Dagli M, Eryilmaz A, Besler T, Akmansu H, Acar A, Korkmaz H. Laryngoscope; 2004 Jul; 114(7):1200-3. PubMed ID: 15235348 [Abstract] [Full Text] [Related]
45. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Frey BN, Andreazza AC, Kunz M, Gomes FA, Quevedo J, Salvador M, Gonçalves CA, Kapczinski F. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):283-5. PubMed ID: 16859818 [Abstract] [Full Text] [Related]
46. Clinical predictors of unrecognized bipolar I and II disorders. Mantere O, Suominen K, Arvilommi P, Valtonen H, Leppämäki S, Isometsä E. Bipolar Disord; 2008 Mar 30; 10(2):238-44. PubMed ID: 18271902 [Abstract] [Full Text] [Related]
48. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood. Dalgiç B, Sönmez N, Biberoğlu G, Hasanoğlu A, Erbaş D. Turk J Gastroenterol; 2005 Mar 30; 16(1):7-11. PubMed ID: 16252181 [Abstract] [Full Text] [Related]
49. The relationship between potency of oxidative stress and severity of dilated cardiomyopathy. Demirbag R, Yilmaz R, Erel O, Gultekin U, Asci D, Elbasan Z. Can J Cardiol; 2005 Aug 30; 21(10):851-5. PubMed ID: 16107908 [Abstract] [Full Text] [Related]
50. Measurement of the placental total antioxidant status in preeclamptic women using a novel automated method. Ozturk E, Balat O, Acılmıs YG, Ozcan C, Pence S, Erel Ö. J Obstet Gynaecol Res; 2011 Apr 30; 37(4):337-42. PubMed ID: 21314804 [Abstract] [Full Text] [Related]
51. TRPM2 variants and bipolar disorder risk: confirmation in a family-based association study. Xu C, Li PP, Cooke RG, Parikh SV, Wang K, Kennedy JL, Warsh JJ. Bipolar Disord; 2009 Feb 30; 11(1):1-10. PubMed ID: 19133961 [Abstract] [Full Text] [Related]
57. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Lagrange-Puget M, Durieu I, Ecochard R, Abbas-Chorfa F, Drai J, Steghens JP, Pacheco Y, Vital-Durand D, Bellon G. Pediatr Pulmonol; 2004 Jul 30; 38(1):43-9. PubMed ID: 15170872 [Abstract] [Full Text] [Related]
58. Serum oxidant/antioxidant status in patients with Behçet's disease. Taysi S, Kocer I, Memisogullari R, Kiziltunc A. Ann Clin Lab Sci; 2002 Jul 30; 32(4):377-82. PubMed ID: 12458889 [Abstract] [Full Text] [Related]
59. Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restricted infants. Toy H, Camuzcuoglu H, Arioz DT, Kurt S, Celik H, Aksoy N. J Obstet Gynaecol Res; 2009 Dec 30; 35(6):1047-53. PubMed ID: 20144170 [Abstract] [Full Text] [Related]